Literature DB >> 1535146

[Compared bioavailability of methotrexate administered orally or intramuscularly in rheumatoid arthritis].

B Auvinet, I Jarrier, F Le Levier, Y Pegon, A Turcant, P Allain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1535146

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 2.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.

Authors:  C Lebbe; C Beyeler; N J Gerber; J Reichen
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

4.  Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.

Authors:  Winfried Demary; Holger Schwenke; Karin Rockwitz; Peter Kästner; Anke Liebhaber; Ulrich Schoo; Georg Hübner; Uwe Pichlmeier; Cécile Guimbal-Schmolck; Ulf Müller-Ladner
Journal:  Patient Prefer Adherence       Date:  2014-08-06       Impact factor: 2.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.